30 November 2013

Just Dial : Takeaways from Citi India Internet Corporate Day

Just Dial (JUST.BO)
Alert: Takeaways from Citi India Internet Corporate Day
 Takeaways from Mumbai – Just Dial (JUST) presented at the Citi India Internet
Corporate Day in Mumbai today. We present key takeaways below:
 Focus is on new services beyond the legacy search business –
– Quick Quote – Plans to launch quick quote service in the next 1 month, which
will be an enhanced service over existing best deal. In addition to competitive
pricing, JUST believes that its tie-up with local vendors should help the customer
potentially get same-day fulfillment (delivery) given their proximity.
– Transaction services – The company believes its long history and brand should
help increase user comfort, the biggest challenge for online transactions. JUST
has already launched service for ordering food, wine and booking a table in a
restaurant and has a host of other services in the pipeline. The goal over the next
3-4 quarters is to create awareness and win consumer mindshare rather than
revenue/profit generation. Eventually, it could start charging based on a
commission structure (on value of transaction). Longer term, the company’s
ambition is to try and charge 1% of the household spend across transactions as
commission. However, all services would remain free for the end consumer.
 Little impact from economic slowdown – Management believes that the
economic slowdown has little impact on the company’s growth prospects given the
high reliance of many SMEs on attracting business from Just Dial’s user queries.
However, churn does go up in a slowdown as incidence of SME failure rate
increases (anyways is an ongoing trend).
 Focus on margins vs. accelerating topline – The company could accelerate
topline from the current ~30%yoy by sacrificing margins (increase sales force;
reduce target productivity metric for the sales force). However the aim is to sustain
and grow margins. Currently, it tries to generate 3x returns on its sales force spend.

Morgan Stanley -Sun Pharmaceutical

Sun Pharmaceutical
Industries
Taro Tender Offer Suggests
Inexpensive Valuations?
Quick Comment: Taro (US$4bn market cap, 65.9%
owned by Sun) announced that it has commenced
repurchase of its ordinary shares (up to US$200mn) at a
price not greater than US$97.5 per share nor less than
US$84.5 per share. At these prices, if the offer is fully
subscribed, the number of shares to be purchased
represents approximately 4.6-5.3% of Taro’s currently
issued shares. The offer will expire at midnight (EST) on
December 23, 2013.
Rationale: Taro had approximately US$741mn in cash
as of October 31, 2013. The company said it aims to
return part of this cash to shareholders through this
tender offer and retain the balance for future use. The
annualized F2Q14 results (US$96mn net profit), which
may be sustainable if competition intensifies, implies
9.5-11x P/E multiples (at extreme end of offer pricing).
Taro stock is up 96% YTD and significantly vs. Sun’s
acquisition value (roughly US$260m for 66% stake three
to four years ago).
Implication: Taro’s tender offer at the current stock
price suggests management’s assessment for greater
value in the stock. Alternatively, the decision may be
driven by the low fixed-income yield on the surplus cash.
It would be interesting to note Sun’s reaction to this offer
(i.e., whether it participates or not). If it participates, then
we believe that will lead to a transfer of excess cash
from Taro to Sun. Both companies are generating strong
cash flow.
Investment thesis: We expect strong growth trajectory
for Sun in the quarters ahead driven by its solid base
business, value unlocking in URL/DUSA and greater
market share in Doxil. Surplus cash on the balance
sheet should add an M&A premium to the stock. We
retain our OW rating on the stock and it is part of our
Asia Best Ideas list.

GMDC Ltd- Company update- Worst over, smart production uptick ahead, maintain Buy: centrum

Rating: Buy; Target Price: Rs150; CMP: Rs102; Upside:47.3%



Worst over, smart production uptick ahead, maintain Buy



We maintain Buy on GMDC with an increased TP of Rs150. Our recent
visit to the company’s Bhavnagar mine and interaction with management
cemented our view of sharp volume recovery ahead and worst being past.
Current undemanding valuations probably indicate investors’ extreme
scepticism on a near-term volume recovery/price hikes. The dismal
production for YTDFY14 was largely due to heavy monsoons, while
production issues (hard strata, thin seam) have already been tackled.
The land acquisition for overburden dumping that is still pending is
likely to be resolved in the near future, offering additional volume
upside. We have increased our volume estimates for FY14E/15E and
adjusted realizations & costs leading to upward revision in EBITDA
estimates by 2.1%/10.3%.

MRF- Result Update - Stays on course; maintain Buy: Centrum

Rating: Buy; Target Price: Rs 21,000, CMP: Rs 17,559; Upside: 20%



Stays on course; maintain Buy



Stays on course; maintain Buy

We retain Buy on MRF with a revised TP of Rs21,000 driven by upward
revision in earnings and PE expansion. Our confidence is driven by its
ability to maintain better than industry growth and sustain strong
margin profile. On a QoQ basis, MRF’s revenue growth was 3% against a
drop for the industry. Also, margin profile continues to remain strong
at 13.8% vs. peers  avg. of 12.5% excluding MRF. We believe MRF is
better placed to ride the recovery expected over FY14E-FY15E led by
the pickup in replacement demand and higher OEM growth.

Power Grid _FPO : Price Band , Lot Size & Discount Details

Please find below the details of price band, lot size and discount details for PGCIL FPO

Price Band: Rs. 85 - 90 per share

Discount for retail and employees: Rs. 4.5 on the offer price
Minimum bid lot: 150 shares

Warm Regards,




--